Key result
Ovariectomy spares glucose tolerance but reduces heart weight and alters cardiac enzymes in rats.
Why the study?
The impact of menopause on glucose tolerance, insulin resistance, body weight, heart size, and cardiac energy metabolism in hypertensive female rats was unclear.
Does ovariectomy alter glucose tolerance, insulin resistance, and cardiac energy metabolism in middle-aged female spontaneously hypertensive rats?
Does ovariectomy alter glucose tolerance, insulin resistance, and cardiac energy metabolism in middle-aged female spontaneously hypertensive rats?
In middle-aged female hypertensive rats, ovariectomy does not worsen glucose tolerance but may negatively impact cardiac glucose metabolism and heart size maintenance.
These rat findings leave open direct cardiac effects of estrogen loss independent of glucose tolerance; no clinical translation warranted.
Insulin resistance is a risk factor for coronary heart disease. The protection of young women from coronary events is sharply reduced with menopause. To assess the impact of menopause on glucose tolerance, insulin resistance, body weight gain, heart size, and cardiac energy metabolism, we studied 28-week-old female SHR and Wistar-Kyoto (WKY) rats, who were either ovariectomized (SHR(OVX) and WKY(OVX)) or sham-operated (SHR(SHAM) and WKY(SHAM)). Animals underwent blood-pressure measurement and an oral glucose tolerance test (OGTT). Hearts were weighed and assayed for metabolic enzyme activities. Female SHR were 33 % lighter and hypertensive (+ 36 mmHg), with 33 % larger hearts (when corrected for body weight differences) compared to WKY. Although ovariectomized animals of both strains were heavier overall than their sham-operated counterparts, when heart weights were corrected for body weight, both OVX strains had lighter hearts than both SHAM strains. Glucose and insulin responses during OGTT were similar between the four groups; however, free fatty acid (FFA) responses were approximately 50 % greater in SHR than WKY, although less in SHR(OVX) than SHR(SHAM). WKY(OVX) demonstrated 8 % lower ventricular hexokinase activity than WKY(SHAM), which may reflect reduced cardiac glucose utilization. We also noted 16 % higher citrate synthase activity in WKY hearts. In conclusion, the insulin resistance characteristic of younger SHR is blunted in middle-aged female rats, although FFA responses remain elevated. Ovariectomy did not alter in vivo glucose tolerance in this group; however, sex hormones may be important in maintaining normal heart size and the potential for cardiac glucose metabolism.
No takes yet. Share an insight, caveat, or question.
Swislocki et al. (2002) studied Insulin resistance and hypertension. Ovariectomy vs. Sham operation was evaluated on Glucose tolerance, insulin resistance, body weight gain, heart size, and cardiac energy metabolism. Ovariectomy did not alter in vivo glucose tolerance in middle-aged female rats, but resulted in lighter heart weights and altered cardiac enzyme activities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: